Joel Jiang Selected Research

Programmed Cell Death 1 Receptor

1/2019

Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy: Three-Year Follow-up of a Randomized Phase 3 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joel Jiang Research Topics

Disease

9	Melanoma (Melanoma, Malignant) 01/2019 - 07/2015
5	Disease Progression 01/2022 - 07/2015
3	Colitis 11/2018 - 07/2016
3	Body Weight (Weight, Body) 08/2018 - 08/2013
3	Neoplasms (Cancer) 08/2018 - 07/2015
3	Infections 03/2015 - 05/2008
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2022 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 03/2015 - 08/2013
1	Cardiomyopathies (Cardiomyopathy) 11/2018
1	Necrosis 11/2018
1	Neutropenia 11/2018
1	Neoplasm Metastasis (Metastasis) 08/2018
1	Neurologic Manifestations (Neurological Manifestations) 08/2018
1	Brain Neoplasms (Brain Tumor) 08/2018
1	Hypophysitis 11/2016
1	Renal Cell Carcinoma (Grawitz Tumor) 09/2016
1	Hypovolemia 03/2015
1	Hypoglycemia (Reactive Hypoglycemia) 03/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2013
1	Intraabdominal Infections 05/2008

Drug/Important Bio-Agent (IBA)

10	NivolumabIBA 01/2019 - 07/2015
7	IpilimumabIBA 11/2018 - 07/2015
3	atalurenIBA 01/2022 - 01/2020
2	Nonsense Codon (Nonsense Mutation)IBA 01/2022 - 01/2020
2	Lipase (Acid Lipase)FDA Link 11/2018 - 07/2016
2	Immune Checkpoint InhibitorsIBA 09/2016 - 07/2016
2	CanagliflozinIBA 03/2015 - 08/2013
2	Glucose (Dextrose)FDA LinkGeneric 03/2015 - 08/2013
1	idebenoneIBA 01/2022
1	TAS-205IBA 01/2022
1	edasalonexentIBA 01/2022
1	GlucocorticoidsIBA 01/2022
1	eteplirsenIBA 01/2022
1	VBP15 compoundIBA 01/2022
1	Oxandrolone (Anavar)FDA LinkGeneric 01/2022
1	PRO051IBA 01/2022
1	Dacarbazine (DIC)FDA LinkGeneric 01/2019
1	Programmed Cell Death 1 ReceptorIBA 01/2019
1	CTLA-4 AntigenIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 11/2016
1	Proto-Oncogene Proteins B-rafIBA 07/2015
1	Investigational DrugsIBA 07/2015
1	Insulin (Novolin)FDA Link 03/2015
1	Sodium-Glucose Transport ProteinsIBA 03/2015
1	SodiumIBA 08/2013
1	Blood Glucose (Blood Sugar)IBA 08/2013
1	SymportersIBA 08/2013
1	Meropenem (Merrem)FDA LinkGeneric 05/2008
1	Doripenem FDA Link 05/2008

Therapy/Procedure

7	Therapeutics 01/2019 - 05/2008
1	Orthotic Devices (Orthosis) 01/2022
1	Intravenous Infusions 11/2016
1	Glycemic Control 03/2015
1	Drug Therapy (Chemotherapy) 05/2008